by Wisell, K.T. et al.
Department of Antibiotic Resistance and Hospital Hygiene, Swedish Institute for Infectious Disease Control, 17182 Solna, Sweden
Department of Antibiotic Resistance and Hospital Hygiene, Swedish Institute for Infectious Disease Control, 17182 Solna, Sweden
The European Committee on Antimicrobial Susceptibility Testing and the national breakpoint committees in Europe have recently debated the role of trimethoprim in the treatment of enterococcal UTI and agreed to categorize wild-type enterococci as intermediate to trimethoprim and trimethoprim/sulfamethoxazole.
J. Antimicrob. Chemother. 2008; 1:35-40